Reversed TESS Shoulder Artroplasty

NCT01877434 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2013-06-13

No results posted yet for this study

Summary

Reverse total shoulder arthroplasty (RSA) is a accepted treatment for different shoulder diseases with improved functional outcome. This study has evaluated patients operated with reversed shoulder arthroplasty after 1,5-3 years postoperatively with patient reported outcome, clinical and radiological examination, complication and reoperations. The radiologic phenomenom and clinical impact of scapular notching (SN) and arm length difference has been evaluated.

Conditions

  • Humerus Fracture
  • Degenerative Shoulder Pain
  • Degenerative Supraspinatus Rupture

Interventions

PROCEDURE

Reversed shoulder arthroplasty

Sponsors & Collaborators

  • Sundsvall Hospital

    lead OTHER

Eligibility

Min Age
60 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2012-01-31
Completion
2013-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01877434 on ClinicalTrials.gov